Drug Shortage Report for ADALAT XL - SRT 20MG
| Report ID | 48932 |
| Drug Identification Number | 02237618 |
| Brand name | ADALAT XL - SRT 20MG |
| Common or Proper name | Nifedipine extended-release tablets Bayer Standard |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NIFEDIPINE |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 28's and 98's |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-05-09 |
| Estimated end date | 2018-09-15 |
| Actual end date | 2018-08-14 |
| Shortage status | Resolved |
| Updated date | 2018-08-15 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.